The patient underwent sars-cov-2 antigen test on (b)(6) 2021, and the feedback was "when using the lepu sars-cov-2 antigen test, a super faint line was noticed.However, the hotgen test conducted the next day came back negative, so i'm not sure if the product gave the wrong test result, which could be very misleading." after receiving the above feedback information, the leadership of our company attached great importance to it and immediately organized relevant personnel to conduct an investigation and analysis.According to the feedback information, we know that this product problem report is from hungary.Our products sold in the eu market are registered as required, check the ce certification, the scope of the certificate does not cover reagent testing products, and the company has not submitted an application for registration of such products to the certification body.After investigation, the sars-cov-2 antigen detection product in this case report was not produced by our company.
|